|
"lu ys"的相關文件
顯示項目 21-30 / 44 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2008-08 |
Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells
|
Chen, KF;Yeh, PY;Yeh, KH;Lu, YS;Huang, SY;Cheng, AL |
| 國立臺灣大學 |
2008-06 |
Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients.
|
Kuo, SH; Lien, HC; You, SL; Lu, YS; Lin, CH; Chen, TZ; Huang, CS. |
| 國立臺灣大學 |
2008-06 |
The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.
|
Huang, CS; Kuo, SH; Lien, HC; Yang, SY; You, SL; Shen, CY; Lin, CH; Lu, YS; Chang, KJ. |
| 國立臺灣大學 |
2008-02 |
Differential expression of glucocorticoid receptor in carcinomas of the human digestive system
|
Lien, HC; Lu, YS; Shun, CT; Yao, YT; Chang, WC; Cheng, AL |
| 國家衛生研究院 |
2007-06-01 |
Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation
|
Chen, CS; Wang, YC; Yang, HC; Huang, PH; Kulp, SK; Yang, CC; Lu, YS; Matsuyama, S; Chen, CY; Chen, CS |
| 國立臺灣大學 |
2007-03 |
Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.
|
Chen, CS; Wang, YC; Yang, HC; Huang, PH; Kulp, SK; Yang, CC; Lu, YS; Matsuyama, S; Chen, CY; Chen, CS |
| 國立臺灣大學 |
2007-02 |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
|
Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH. |
| 國立臺灣大學 |
2007-02 |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer.
|
Lin, CC; Cheng, AL; Hsu, CH; Lu, YS; Hsu, C; Kun-Huei, Yeh; Wu, CY; Huang, CS; Yang, CH. |
| 國立臺灣大學 |
2006-12 |
Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors.
|
Lu, YS; Lien, HC; Yeh, PY; Yeh, KH; Kuo, ML; Kuo, SH; Cheng, AL. |
| 國家衛生研究院 |
2006-05 |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang, HJ; Wang, CC; Cheng, AL; Hsu, C; Lu, YS; Chang, MC; Lin, JT; Wang, HP; Shiah, HS; Liu, TW; Chang, JY; Whang-Peng, J; Chen, LT |
顯示項目 21-30 / 44 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
